Search Results - "Klein, A.B."

5-HT2A and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and High- (RHA) avoidance rat strains by Klein, A.B, Ultved, L, Adamsen, D, Santini, M.A, Tobeña, A, Fernandez-Teruel, A, Flores, P, Moreno, M, Cardona, D, Knudsen, G.M, Aznar, S, Mikkelsen, J.D

“…Highlights • Roman Low- and High-Avoidance (RLA and RHA) rats differ in 5-HT2A R binding. • 5-HT2A R binding correlated with impulsivity in RHA rats. • SERT…”
Get full text

Changes in 5-HT2A -mediated behavior and 5-HT2A - and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice by Klein, A.B, Santini, M.A, Aznar, S, Knudsen, G.M, Rios, M

“…Abstract Changes in brain-derived neurotrophic factor (BDNF) expression have been implicated in the etiology of psychiatric disorders. To investigate…”
Get full text

Novelty-induced activity-regulated cytoskeletal-associated protein ( Arc ) expression in frontal cortex requires serotonin 2A receptor activation by Santini, M.A, Klein, A.B, El-Sayed, M, Ratner, C, Knudsen, G.M, Mikkelsen, J.D, Aznar, S

“…Abstract Many psychiatric disorders are characterized by cognitive and emotional alterations that are related to abnormal function of the frontal cortex (FC)…”
Get full text

1249P PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark by Cronin-Fenton, D., Dalvi, T., Movva, N., Pedersen, L., Hansen, H., Fryzek, J., Mellemgaard, A., Rasmussen, T., Klein, A.B., Hamilton-Dutoit, S., Nørgaard, M.

Get full text

1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy by Girard, N., Fietkau, R., Garassino, M., Garrido, P., Field, J.K., Peters, S., Smit, H.J.M., Pérol, M., Merle, P., Sibille, A., Markman, B., Bouchaab, H., Moskovitz, M., Schumann, C., Gregorc, V., Klein, A.B., Diaz Perez, I., Sawyer, W., Licour, M., Christoph, D.

Get full text

PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy by Girard, N., Mornex, F., Christoph, D.C., Fietkau, R., Filippi, A.R., Field, J., Garrido Lopez, P., McDonald, F., Peters, S., Klein, A.B., Licour, M., Garassino, M.C.

Get full text

Match-adjusted indirect comparison of durvalumab and chemotherapy for locally advanced or metastatic urothelial carcinoma (UC) following failure of platinum-based therapy by Hoyle, C.K., Klein, A.B., Patel, K.A., Shire, N., Wang, H., Chu, B.C., Ouwens, M., Nordstrom, B.L., Horne, L., Arkenau, H.-T.

Get full text

Autoradiographic imaging and quantification of the high-affinity GHB binding sites in rodent brain using 3H-HOCPCA by Klein, A.B., Bay, T., Villumsen, I.S., Falk-Petersen, C.B., Marek, A., Frølund, B., Clausen, R.P., Hansen, H.D., Knudsen, G.M., Wellendorph, P.

“…GHB (γ-hydroxybutyric acid) is a compound endogenous to mammalian brain with high structural resemblance to GABA. GHB possesses nanomolar-micromolar affinity…”
Get full text

Increased susceptibility to diet-induced obesity in GPRC6A receptor knockout mice by Clemmensen, C., Smajilovic, S., Madsen, A.N., Klein, A.B., Holst, B., Bräuner-Osborne, H.

Get full text

Comparison of spinal mobility and isometric trunk extensor forces with electromyographic spectral analysis in identifying low back pain by Klein, A B, Snyder-Mackler, L, Roy, S H, DeLuca, C J

“…This study compared conventional clinical measurements with electromyographic (EMG) spectral measurements for identification of individuals with low back pain…”
Get more information